Heart Test Laboratories Stock Analysis

HSCS Stock  USD 3.30  0.03  0.92%   
Heart Test Laboratories is undervalued with Real Value of 5.74 and Target Price of 13.5. The main objective of Heart Test stock analysis is to determine its intrinsic value, which is an estimate of what Heart Test Laboratories is worth, separate from its market price. There are two main types of Heart Test's stock analysis: fundamental analysis and technical analysis.
The Heart Test stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Heart Test is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Heart Stock trading window is adjusted to America/New York timezone.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Heart Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.81. Some equities with similar Price to Book (P/B) outperform the market in the long run. Heart Test Laboratories recorded earning per share (EPS) of 5.35. The entity had not issued any dividends in recent years. The firm had 1:100 split on the 17th of May 2024. Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To learn more about Heart Test Laboratories call Andrew Simpson at 682-237-7781 or check out https://heartsciences.com.

Heart Test Laboratories Investment Alerts

Heart Test had very high historical volatility over the last 90 days
Heart Test has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 18.6 K. Net Loss for the year was (6.61 M) with profit before overhead, payroll, taxes, and interest of 12.52 K.
Heart Test Laboratories currently holds about 4.27 M in cash with (6.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Heart Test has a poor financial position based on the latest SEC disclosures
Latest headline from news.google.com: Heart Test Labs Announces Stock Options and Leadership Changes - TipRanks

Heart Test Laboratories Upcoming and Recent Events

21st of March 2024
Upcoming Quarterly Report
View
31st of January 2024
Next Fiscal Quarter End
View

Heart Largest EPS Surprises

Earnings surprises can significantly impact Heart Test's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-03-14
2024-01-31-0.06-0.030.0350 
2023-12-14
2023-10-31-0.12-0.16-0.0433 
2023-07-19
2023-04-30-0.16-0.21-0.0531 
View All Earnings Estimates

Heart Test Environmental, Social, and Governance (ESG) Scores

Heart Test's ESG score is a quantitative measure that evaluates Heart Test's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Heart Test's operations that may have significant financial implications and affect Heart Test's stock price as well as guide investors towards more socially responsible investments.

Heart Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Citadel Advisors Llc2024-06-30
0.0
Cultivar Capital Inc2024-09-30
0.0
Morgan Stanley - Brokerage Accounts2024-09-30
0.0
Accurate Wealth Management, Llc2024-06-30
0.0
Xtx Topco Ltd2024-06-30
0.0
First Western Trust Bank2024-06-30
0.0
Alphastar Insurance Group Ltd2024-06-30
0.0
Fidelity Management And Research Company2024-06-30
0.0
Chapin Davis Inc2024-06-30
0.0
Hrt Financial Llc2024-09-30
10.2 K
Tower Research Capital Llc2024-09-30
1.9 K
Note, although Heart Test's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Heart Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.24 M.

Heart Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.96)(1.01)
Return On Capital Employed(0.73)(0.77)
Return On Assets(0.80)(0.84)
Return On Equity(1.04)(1.09)

Management Efficiency

Heart Test Laboratories has return on total asset (ROA) of (0.8169) % which means that it has lost $0.8169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.6929) %, meaning that it created substantial loss on money invested by shareholders. Heart Test's management efficiency ratios could be used to measure how well Heart Test manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.01 in 2025. Return On Capital Employed is likely to drop to -0.77 in 2025. At this time, Heart Test's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 217.5 K in 2025, whereas Intangible Assets are likely to drop slightly above 1.3 M in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 18.68  19.62 
Tangible Book Value Per Share 14.62  15.36 
Enterprise Value Over EBITDA 0.22  0.23 
Price Book Value Ratio 0.51  0.49 
Enterprise Value Multiple 0.22  0.23 
Price Fair Value 0.51  0.49 
Enterprise Value-1.7 M-1.7 M
Heart Test showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Operating Margin
(379.07)
Beta
3.294
Return On Assets
(0.82)
Return On Equity
(2.69)

Technical Drivers

As of the 31st of January, Heart Test retains the risk adjusted performance of 0.0336, and Market Risk Adjusted Performance of (0.48). Heart Test technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Heart Test Laboratories coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Heart Test is priced fairly, providing market reflects its last-minute price of 3.3 per share. Given that Heart Test Laboratories has jensen alpha of 0.1854, we strongly advise you to confirm Heart Test Laboratories's regular market performance to make sure the company can sustain itself at a future point.

Heart Test Laboratories Price Movement Analysis

Execute Study
The output start index for this execution was fourty-four with a total number of output elements of seventeen. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Heart Test middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Heart Test Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Heart Test Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heart Test insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heart Test's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Heart Test insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Heart Test Outstanding Bonds

Heart Test issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Heart Test Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Heart bonds can be classified according to their maturity, which is the date when Heart Test Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Heart Test Predictive Daily Indicators

Heart Test intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Heart Test stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Heart Test Corporate Filings

F4
23rd of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
21st of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
19th of December 2024
Other Reports
ViewVerify
17th of December 2024
Other Reports
ViewVerify
10Q
16th of December 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
8th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
21st of October 2024
An amendment to a previously filed Form 8-K
ViewVerify
8K
18th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Heart Test Forecast Models

Heart Test's time-series forecasting models are one of many Heart Test's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Heart Test's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Heart Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Heart Test prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Heart shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Heart Test. By using and applying Heart Stock analysis, traders can create a robust methodology for identifying Heart entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(408.39)(428.81)
Operating Profit Margin(389.87)(409.37)
Net Loss(408.39)(428.81)
Gross Profit Margin 0.61  0.39 

Current Heart Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Heart analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Heart analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
13.5Strong Buy2Odds
Heart Test Laboratories current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Heart analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Heart stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Heart Test Laboratories, talking to its executives and customers, or listening to Heart conference calls.
Heart Analyst Advice Details

Heart Stock Analysis Indicators

Heart Test Laboratories stock analysis indicators help investors evaluate how Heart Test stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Heart Test shares will generate the highest return on investment. By understating and applying Heart Test stock analysis, traders can identify Heart Test position entry and exit signals to maximize returns.
Begin Period Cash Flow1.7 M
Common Stock Shares Outstanding352.5 K
Total Stockholder Equity7.3 M
Property Plant And Equipment Net560 K
Cash And Short Term Investments5.8 M
Cash5.8 M
Accounts Payable448.2 K
Net Debt-4.8 M
50 Day M A3.4357
Total Current Liabilities1.8 M
Other Operating Expenses6.3 M
Non Current Assets Total2.1 M
Stock Based Compensation405 K

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.